These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32364063)

  • 21. Rational, computer-enabled peptide drug design: principles, methods, applications and future directions.
    Diller DJ; Swanson J; Bayden AS; Jarosinski M; Audie J
    Future Med Chem; 2015; 7(16):2173-93. PubMed ID: 26510691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational Studies in Drug Design Against Cancer.
    De B; Bhandari K; Mendonça FJB; Scotti MT; Scotti L
    Anticancer Agents Med Chem; 2019; 19(5):587-591. PubMed ID: 30207247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitors.
    Santos LH; Ferreira RS; Caffarena ER
    Mem Inst Oswaldo Cruz; 2015 Nov; 110(7):847-64. PubMed ID: 26560977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
    Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
    Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Updates on Computer-aided Drug Discovery: Time for a Paradigm Shift.
    Usha T; Shanmugarajan D; Goyal AK; Kumar CS; Middha SK
    Curr Top Med Chem; 2017; 17(30):3296-3307. PubMed ID: 29295698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico modelling of ADMET-a minireview of work from 2000 to 2004.
    Norinder U
    SAR QSAR Environ Res; 2005; 16(1-2):1-11. PubMed ID: 15844440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insilico Approaches in Anesthetic Drug Development: Computer Aided Drug Designing.
    Peng QX; Guan XH; Yi ZG; Su YP
    Drug Res (Stuttg); 2015 Nov; 65(11):587-91. PubMed ID: 25463595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Pharmacophore Concept and Its Applications in Computer-Aided Drug Design.
    Seidel T; Schuetz DA; Garon A; Langer T
    Prog Chem Org Nat Prod; 2019; 110():99-141. PubMed ID: 31621012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computer-aided design of amino acid-based therapeutics: a review.
    Farhadi T; Hashemian SM
    Drug Des Devel Ther; 2018; 12():1239-1254. PubMed ID: 29795978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational modulator design by exploitation of protein-protein complex structures.
    Wichapong K; Poelman H; Ercig B; Hrdinova J; Liu X; Lutgens E; Nicolaes GA
    Future Med Chem; 2019 May; 11(9):1015-1033. PubMed ID: 31141413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of ADME characteristics in drug discovery and their in silico evaluation: in silico screening of chemicals for their metabolic stability.
    Gombar VK; Silver IS; Zhao Z
    Curr Top Med Chem; 2003; 3(11):1205-25. PubMed ID: 12769701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting molecular interactions in silico: I. A guide to pharmacophore identification and its applications to drug design.
    Dror O; Shulman-Peleg A; Nussinov R; Wolfson HJ
    Curr Med Chem; 2004 Jan; 11(1):71-90. PubMed ID: 14754427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of peptide and protein based radiopharmaceuticals.
    Wynendaele E; Bracke N; Stalmans S; De Spiegeleer B
    Curr Pharm Des; 2014; 20(14):2250-67. PubMed ID: 24025103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of machine learning approaches for novel drug discovery.
    Lima AN; Philot EA; Trossini GH; Scott LP; Maltarollo VG; Honorio KM
    Expert Opin Drug Discov; 2016; 11(3):225-39. PubMed ID: 26814169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combating Diseases with Computational Strategies Used for Drug Design and Discovery.
    Makhouri FR; Ghasemi JB
    Curr Top Med Chem; 2018; 18(32):2743-2773. PubMed ID: 30663568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives.
    Breeman WA; de Blois E; Sze Chan H; Konijnenberg M; Kwekkeboom DJ; Krenning EP
    Semin Nucl Med; 2011 Jul; 41(4):314-21. PubMed ID: 21624565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computer-Aided Antibody Design: An Overview.
    Choong YS; Lee YV; Soong JX; Law CT; Lim YY
    Adv Exp Med Biol; 2017; 1053():221-243. PubMed ID: 29549642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Docking, In-Silico ADMET Study and Development of 1,6- Dihydropyrimidine Derivative as Protein Tyrosine Phosphatase Inhibitor: An Approach to Design and Develop Antidiabetic Agents.
    Patel AD; Barot R; Parmar I; Panchal I; Shah U; Patel M; Mishtry B
    Curr Comput Aided Drug Des; 2018; 14(4):349-362. PubMed ID: 29701158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer's Agents.
    Pandey S; Singh BK
    Curr Comput Aided Drug Des; 2020; 16(1):54-72. PubMed ID: 30827255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of chiral chromatography in radiopharmaceutical fields: A review.
    Moein MM; Tran TA
    J Chromatogr A; 2020 Nov; 1632():461611. PubMed ID: 33086153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.